BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3454807)

  • 1. Beta=interferon in the treatment of 14 patients with advanced colorectal carcinoma.
    Pitini V; Palmara D; Ferraro G; Zanghi M; La Torre F; Tomasella R; Chille G
    J Exp Pathol; 1987; 3(4):603-5. PubMed ID: 3454807
    [No Abstract]   [Full Text] [Related]  

  • 2. Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.
    Triozzi PL; Kenney P; Young D; Rinehart JJ
    Cancer Treat Rep; 1987 Oct; 71(10):983-4. PubMed ID: 3308083
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of recombinant beta interferon in advanced colorectal cancer.
    Lillis PK; Brown TD; Beougher K; Koeller J; Marcus SG; Von Hoff DD
    Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses.
    Krown SE; Mintzer D; Cunningham-Rundles S; Niedzwiecki D; Krim M; Einzig AI; Gabrilove JL; Shurgot B; Gessula J
    Cancer Treat Rep; 1987 Jan; 71(1):39-45. PubMed ID: 3791267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
    Chaplinski T; Laszlo J; Moore J; Silverman P
    Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA; Callaghan M; Sarna G
    Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of high-dose recombinant leukocyte alpha-2 interferon for metastatic colorectal cancer without previous systemic treatment.
    Eggermont AM; Weimar W; Marquet RL; Laméris JD; Jeekel J
    Cancer Treat Rep; 1985 Feb; 69(2):185-7. PubMed ID: 3882227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity.
    Tank B; Marquet RL; Weimar W; Westbroek DL
    Br J Cancer; 1984 Aug; 50(2):227-30. PubMed ID: 6466539
    [No Abstract]   [Full Text] [Related]  

  • 9. [Colorectal cancer in young patients].
    Vorlícek J; Vrbková J; Konecný M; Reisinger H
    Vnitr Lek; 1985 Nov; 31(11):1063-7. PubMed ID: 4072025
    [No Abstract]   [Full Text] [Related]  

  • 10. A Phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancer.
    Silgals RM; Ahlgren JD; Neefe JR; Rothman J; Rudnick S; Galicky FP; Schein PS
    Cancer; 1984 Nov; 54(10):2257-61. PubMed ID: 6488145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose rDNA human alpha 2 interferon therapy in patients with advanced colorectal adenocarcinoma: a phase II study.
    Lundell G; Blomgren H; Cedermark B; Silfverswärd C; Theve T; Ohman U
    Radiother Oncol; 1984 Mar; 1(4):325-32. PubMed ID: 6505269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of colorectal cancer with monoclonal antibodies].
    Nielsen SE
    Ugeskr Laeger; 1997 May; 159(21):3134-9. PubMed ID: 9198999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy in the treatment of colorectal cancers in the aged].
    Navarra S; Melita P; Di Mauro S
    Minerva Med; 1982 Apr; 73(18):1225-32. PubMed ID: 7078801
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant leukocyte A interferon as single agent therapy or in combination with cimetidine in patients with advanced colo-rectal carcinoma. A phase II investigation.
    Flodgren P; Hugander A; Sjögren HO
    Acta Radiol Oncol; 1985; 24(1):25-34. PubMed ID: 2984899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of intraluminal fluorouracil chemotherapy as an adjuvant to radical resection of colorectal cancers].
    Wan DS
    Zhonghua Zhong Liu Za Zhi; 1983 May; 5(3):193-6. PubMed ID: 6628177
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy in colorectal cancer.
    Wallack MK
    Mo Med; 1981 Jan; 78(1):23-5. PubMed ID: 7219405
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimal activity of recombinant clone a interferon in metastatic colon cancer.
    Neefe JR; Silgals R; Ayoob M; Schein PS
    J Biol Response Mod; 1984 Aug; 3(4):366-70. PubMed ID: 6481401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does maintenance therapy with alpha interferon stabilize cancer growth? A pilot study.
    Laszlo J; Goldstein D; Vugrin D; Hood L; Tso CY
    J Biol Response Mod; 1986 Aug; 5(4):294-9. PubMed ID: 3734845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should colorectal carcinoma be sought in periodic health examinations?--an approach to the evidence.
    Fletcher SW; Dauphinee WD
    Clin Invest Med; 1981; 4(1):23-31. PubMed ID: 7318266
    [No Abstract]   [Full Text] [Related]  

  • 20. Colorectal cancer.
    McDermott FT; Polglase AL; Buzzard AJ; Johnson W; Pihl EA; Hughes ER
    Med J Aust; 1981 Oct; 2(8):412-4. PubMed ID: 7033747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.